Nanoparticle drug delivery systems for cancer treatment (Record no. 71208)

000 -LEADER
fixed length control field 02897cam a2200529Ki 4500
001 - CONTROL NUMBER
control field 9780429341250
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220711212411.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200222s2020 si o 000 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781000681413
-- (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1000681416
-- (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9780429341250
-- (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 0429341253
-- (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781000680874
-- (electronic bk. : PDF)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1000680878
-- (electronic bk. : PDF)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781000681147
-- (electronic bk. : Mobipocket)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1000681149
-- (electronic bk. : Mobipocket)
082 04 - CLASSIFICATION NUMBER
Call Number 616.994061
245 00 - TITLE STATEMENT
Title Nanoparticle drug delivery systems for cancer treatment
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication Milton :
Publisher Pan Stanford Publishing,
Year of publication 2020.
300 ## - PHYSICAL DESCRIPTION
Number of Pages 1 online resource (342 p.)
500 ## - GENERAL NOTE
Remark 1 Description based upon print version of record.
520 ## - SUMMARY, ETC.
Summary, etc In recent years, nanoparticles--bionanomaterials with specific physicochemical properties--have gained a great deal of scientific interest owing to their unique structure. Nanoparticle-based drugs are now widely regarded as a safer, more precise, and more effective mode of cancer therapy, considering their ability to enhance drug bioavailability, improve site-specific drug delivery, and protect nontarget tissues from toxic therapeutic drugs. This book compiles and details cutting-edge research in nanomedicine from an interdisciplinary team of international cancer researchers who are currently revolutionizing drug delivery techniques through the development of nanomedicines and nanotheranostics. Edited by Hala Gali-Muhtasib and Racha Chouaib, two prominent cancer researchers, this book will appeal to anyone involved in nanotechnology, cancer therapy, or drug delivery research.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
General subdivision Chemotherapy.
700 1# - AUTHOR 2
Author 2 Gali-Muhtasib, Hala,
700 1# - AUTHOR 2
Author 2 Chouaib, Racha,
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier https://www.taylorfrancis.com/books/9780429341250
856 42 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type eBooks
264 #1 -
-- Singapore :
-- Jenny Stanford Publishing,
-- 2019.
588 ## -
-- OCLC-licensed vendor bibliographic record.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Cancer
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Drug delivery systems.
650 #0 - SUBJECT ADDED ENTRY--SUBJECT 1
-- Nanomedicine.
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1
-- MEDICAL / Biotechnology
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1
-- MEDICAL / Oncology
650 #7 - SUBJECT ADDED ENTRY--SUBJECT 1
-- SCIENCE / Biotechnology

No items available.